VCV002573006.1 - ClinVar

NM_024570.4(RNASEH2B):c.64+2_64+6del

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(1)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Likely pathogenic

criteria provided, single submitter

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

NM_024570.4(RNASEH2B):c.64+2_64+6del

Variation ID: 2573006 Accession: VCV002573006.1

Type and length

Deletion, 5 bp

Location

Cytogenetic: 13q14.3 13: 50910142-50910146 (GRCh38) [ NCBI UCSC ] 13: 51484278-51484282 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Jul 22, 2023	Jul 22, 2023	Jan 9, 2023

HGVS

Nucleotide	Protein	Molecular consequence
NM_024570.4:c.64+2_64+6del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.		splice donor
NM_001142279.2:c.64+2_64+6del		splice donor
NM_001411023.1:c.64+2_64+6del		splice donor
NC_000013.11:g.50910142_50910146del
NC_000013.10:g.51484278_51484282del
NG_009055.1:g.5387_5391del
NG_187713.1:g.197_201del
LRG_279:g.5387_5391del
LRG_279t1:c.64+2_64+6del

... more HGVS ... less HGVS

Protein change

Other names

Canonical SPDI

NC_000013.11:50910141:TAAAC:

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
LOC130009810	-	-	-	GRCh38	-	75
RNASEH2B		-	-	GRCh38 GRCh37	433	552
RNASEH2B-AS1	-	-	-	GRCh38	-	89

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
Aicardi-Goutieres syndrome 2	Likely pathogenic (1)	criteria provided, single submitter	Jan 9, 2023	RCV003315120.1

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Likely pathogenic (Jan 09, 2023)	criteria provided, single submitter (ICSLVariantClassificationCriteria RUGD 01 April 2020) Method: clinical testing	Aicardi-Goutieres syndrome 2 Affected status: unknown Allele origin: unknown	Illumina Laboratory Services, Illumina Accession: SCV004014703.1 First in ClinVar: Jul 22, 2023 Last updated: Jul 22, 2023	Comment: The RNASEH2B c.64+2_64+6del variant results in the deletion of five nucleotides, including the thymine within the consensus splice donor site, which may result in splicing … (more) The RNASEH2B c.64+2_64+6del variant results in the deletion of five nucleotides, including the thymine within the consensus splice donor site, which may result in splicing defects. To our knowledge, this variant has not been reported in the peer-reviewed literature. This variant is reported in one allele in the Genome Aggregation Database at a frequency of 0.000043 in the European (non-Finnish) population (version 2.1.1). This variant was found in trans with the well known pathogenic variant, c.529G>A (p.Ala177Thr). Based on the available evidence, the c.64+2_64+6del variant is classified as likely pathogenic for Aicardi-Goutieres syndrome. (less)

Comment:

The RNASEH2B c.64+2_64+6del variant results in the deletion of five nucleotides, including the thymine within the consensus splice donor site, which may result in splicing defects. To our knowledge, this variant has not been reported in the peer-reviewed literature. This variant is reported in one allele in the Genome Aggregation Database at a frequency of 0.000043 in the European (non-Finnish) population (version 2.1.1). This variant was found in trans with the well known pathogenic variant, c.529G>A (p.Ala177Thr). Based on the available evidence, the c.64+2_64+6del variant is classified as likely pathogenic for Aicardi-Goutieres syndrome.

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

Citations for germline classification of this variant

There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar.

Text-mined citations for this variant ...

Record last updated Oct 15, 2023

ClinVar Genomic variation as it relates to human health

NM_024570.4(RNASEH2B):c.64+2_64+6del

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...